OncoFirm™ Cancer Biomarker Atlas 2026 First Edition
Coming 2026….
Volume I — Foundations
- Foreword
- About OncoFirm
- Editorial Policy
- Cancer Biology
- Hallmarks of Cancer
- Biomarker Science
- Early Detection
- Precision Oncology
- Diagnostic Technologies
Volume II — Biomarker Atlas
For every biomarker:
- Biological function
- Discovery
- Molecular pathway
- Associated cancers
- Clinical significance
- Detection methods
- Advantages
- Limitations
- Current guideline status
- Evidence summary
- Key publications
Examples include:
- PSA
- CEA
- AFP
- HE4
- CA-125
- CA19-9
- HER2
- EGFR
- KRAS
- BRAF
- PD-L1
- ctDNA
- ctRNA
…covering hundreds more.
Volume III — Cancer Atlas
Dedicated chapters for each major cancer:
- Breast
- Lung
- Colorectal
- Pancreatic
- Liver
- Prostate
- Ovarian
- Gastric
- Kidney
- Bladder
- Brain
- Melanoma
- Leukemia
- Lymphoma
- Multiple Myeloma
Each chapter would include:
- Epidemiology
- Molecular biology
- Biomarker landscape
- Current screening
- Emerging diagnostics
- Guideline summary
- Future research
Volume IV — Technology
- Antigen Technology
- Fluorescent Lateral Flow Platform
- Digital Diagnostic Readers
- AI-Assisted Diagnostics
- Point-of-Care Oncology
- Liquid Biopsy
- Molecular Diagnostics
- Digital Pathology
- AI
- Nanotechnology
- Microfluidics
Volume V — Future
- Multi-Cancer Early Detection
- Proteomics
- Spatial Biology
- Single-Cell Analysis
- AI
- Wearables
- Future Screening